Metraipolis › archive › dc_07e12653f76a

Efficacy of DNA Intercalator-Conjugated Triplex-Forming Oligonucleotide as Anticancer Agent — Europe PMC PMID:40506395

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40506395
DOI
10.1002/cmdc.202500325
License (as archived)
solo-consultazione
Archived
2026-11-09T23:23:41.895Z
SHA-256 of the archived text
7bc9cdfbd061482530ef7abb659c037e036c597bb3bdcff89e052d190d9e4a75
Stable URL of this page
https://metraipolis.com/documento/dc_07e12653f76a

How to cite

Efficacy of DNA Intercalator-Conjugated Triplex-Forming Oligonucleotide as Anticancer Agent — Europe PMC PMID:40506395 — Europe PMC (en), https://europepmc.org/article/MED/40506395 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07e12653f76a (Metraipolis archive dc_07e12653f76a, sha256 7bc9cdfbd061482530ef7abb659c037e036c597bb3bdcff89e052d190d9e4a75)
BibTeX
@misc{dc07e12653f76a,
  title = {Efficacy of DNA Intercalator-Conjugated Triplex-Forming Oligonucleotide as Anticancer Agent — Europe PMC PMID:40506395},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40506395},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07e12653f76a; sha256 7bc9cdfbd061482530ef7abb659c037e036c597bb3bdcff89e052d190d9e4a75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40506395. Agents can read the archived copy with the MCP tool read_document.